Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
-These shortages have forced Hospira to prioritize certain markets, resulting in tightening supply and forcing price increases
However, once diagnosed it presents a difficult management problem in patients suffering from pernicious anemia, as there is no substitute
These demonstrated short-term safety in adults with normal renal and hepatic function
Gottenberg JE, Brocq O, Perdriger A et al (2016) Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first Anti-TNF drug: a randomized clinical trial
US$ 24.73
US$ 21.59
US$ 23.81
US$ 22.07
US$ 21.28
US$ 29.78
